From: Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
Groups
Cases (n)
0 (n, %)
1+~2+ (%)
3+ (%)
P
Nestin
Gliomas
125
22 (17.6)
68 (54.4)
35 (28.0)
< 0.001
Normal
10
9 (90.0)
1(10%)
0 (0)
CD133
27 (21.6)
64 (51.2)
34 (27.2)